. (HTWR)
$57.98 - (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
. (HTWR)
$57.98
- (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$57.98
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$57.98
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Wade Denis Newell | Director | Aug 23, 2016 | Option Exercise | $58.00 | 4,966 | 288,028 | 0 | Aug 24, 2016, 02:42 PM |
Wade Denis Newell | Director | Aug 23, 2016 | Option Exercise | $58.00 | 5,750 | 333,500 | 0 | Aug 24, 2016, 02:42 PM |
Thomas Robert Bain | Director | Aug 23, 2016 | Option Exercise | $58.00 | 4,510 | 261,580 | 0 | Aug 24, 2016, 02:36 PM |
Thomas Robert Bain | Director | Aug 23, 2016 | Option Exercise | $58.00 | 1,000 | 58,000 | 0 | Aug 24, 2016, 02:36 PM |
Strong Mark | Senior VP, R&D and Quality | Aug 23, 2016 | Option Exercise | $58.00 | 3,513 | 203,754 | 0 | Aug 24, 2016, 02:25 PM |
Stockman Robert Bernard | Director | Aug 23, 2016 | Option Exercise | $58.00 | 17,814 | 1,033,212 | 0 | Aug 24, 2016, 02:19 PM |
Schuermann James | SVP, Sales & Marketing | Aug 23, 2016 | Option Exercise | $58.00 | 12,043 | 698,494 | 0 | Aug 24, 2016, 02:11 PM |
OESTERLE STEPHEN N | Director | Aug 23, 2016 | Option Exercise | $58.00 | 1,000 | 58,000 | 0 | Aug 24, 2016, 02:04 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Aug 23, 2016 | Option Exercise | $58.00 | 19,005 | 1,102,290 | 0 | Aug 24, 2016, 01:51 PM |
LaRose Jeffrey | Chief Scientific Officer | Aug 23, 2016 | Option Exercise | $58.00 | 12,482 | 723,956 | 0 | Aug 24, 2016, 01:35 PM |
LARKIN C RAYMOND JR | Director | Aug 23, 2016 | Option Exercise | $58.00 | 8,000 | 464,000 | 0 | Aug 24, 2016, 01:30 PM |
Knopf Lawrence J | General Counsel | Aug 23, 2016 | Option Exercise | $58.00 | 17,608 | 1,021,264 | 0 | Aug 24, 2016, 01:25 PM |
Harrison Seth Loring | Director | Aug 23, 2016 | Option Exercise | $58.00 | 3,500 | 203,000 | 0 | Aug 24, 2016, 01:20 PM |
Harrison Seth Loring | Director | Aug 23, 2016 | Option Exercise | $58.00 | 14,936 | 866,288 | 0 | Aug 24, 2016, 01:20 PM |
Harrison Seth Loring | Director | Aug 23, 2016 | Option Exercise | $58.00 | 133,393 | 7,736,794 | 0 | Aug 24, 2016, 01:20 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 23, 2016 | Option Exercise | $58.00 | 84,345 | 4,892,010 | 0 | Aug 24, 2016, 01:10 PM |
FELDMANN CYNTHIA L | Director | Aug 23, 2016 | Option Exercise | $58.00 | 4,750 | 275,500 | 0 | Aug 24, 2016, 01:05 PM |
BARBERICH TIMOTHY J | Director | Aug 23, 2016 | Option Exercise | $58.00 | 11,107 | 644,206 | 0 | Aug 24, 2016, 12:54 PM |
Strong Mark | Senior VP, R&D and Quality | Jul 22, 2016 | Sale | $57.71 | 1,875 | 108,206 | 4,574 | Jul 25, 2016, 06:08 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Jul 11, 2016 | Sale | $57.68 | 3,125 | 180,250 | 19,005 | Jul 12, 2016, 05:05 PM |
Schuermann James | SVP, Sales & Marketing | Jul 01, 2016 | Sale | $57.77 | 1,000 | 57,770 | 12,043 | Jul 05, 2016, 06:45 PM |
Schuermann James | SVP, Sales & Marketing | Apr 01, 2016 | Sale | $31.36 | 1,000 | 31,360 | 13,043 | Apr 04, 2016, 05:01 PM |
OESTERLE STEPHEN N | Director | Feb 29, 2016 | Buy | $32.17 | 1,000 | 32,170 | 1,000 | Feb 29, 2016, 07:12 PM |
Strong Mark | Senior VP, R&D and Quality | Feb 25, 2016 | Sale | $29.68 | 395 | 11,724 | 3,088 | Feb 26, 2016, 05:04 PM |
Schuermann James | SVP, Sales & Marketing | Feb 25, 2016 | Sale | $29.24 | 601 | 17,573 | 14,243 | Feb 26, 2016, 05:04 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Feb 25, 2016 | Sale | $29.01 | 697 | 20,220 | 15,994 | Feb 26, 2016, 05:03 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 25, 2016 | Sale | $29.18 | 354 | 10,330 | 12,582 | Feb 26, 2016, 05:02 PM |
Knopf Lawrence J | General Counsel | Feb 25, 2016 | Sale | $29.16 | 423 | 12,335 | 17,708 | Feb 26, 2016, 05:02 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 25, 2016 | Sale | $29.20 | 1,990 | 58,101 | 84,841 | Feb 26, 2016, 05:01 PM |
Strong Mark | Senior VP, R&D and Quality | Feb 24, 2016 | Sale | $32.34 | 750 | 24,255 | 3,117 | Feb 25, 2016, 05:26 PM |
Schuermann James | SVP, Sales & Marketing | Feb 24, 2016 | Sale | $32.23 | 287 | 9,250 | 12,932 | Feb 25, 2016, 05:23 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Feb 24, 2016 | Sale | $32.38 | 438 | 14,182 | 15,183 | Feb 25, 2016, 05:21 PM |
Leadley Katrin | Chief Medical Officer | Feb 24, 2016 | Sale | $32.38 | 875 | 28,333 | 0 | Feb 25, 2016, 05:18 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 24, 2016 | Sale | $32.41 | 205 | 6,644 | 11,636 | Feb 25, 2016, 05:12 PM |
Knopf Lawrence J | General Counsel | Feb 24, 2016 | Sale | $32.27 | 287 | 9,261 | 16,831 | Feb 25, 2016, 05:09 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 24, 2016 | Sale | $32.35 | 1,153 | 37,300 | 80,835 | Feb 25, 2016, 05:07 PM |
Schuermann James | SVP, Sales & Marketing | Feb 08, 2016 | Sale | $36.77 | 647 | 23,789 | 12,793 | Feb 09, 2016, 05:06 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Feb 08, 2016 | Sale | $36.85 | 700 | 25,792 | 15,246 | Feb 09, 2016, 05:05 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 08, 2016 | Sale | $36.53 | 560 | 20,456 | 11,491 | Feb 09, 2016, 05:03 PM |
Knopf Lawrence J | General Counsel | Feb 08, 2016 | Sale | $36.49 | 568 | 20,729 | 16,643 | Feb 09, 2016, 05:02 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 08, 2016 | Sale | $36.58 | 1,796 | 65,700 | 79,750 | Feb 09, 2016, 05:01 PM |
Schuermann James | SVP, Sales & Marketing | Jan 04, 2016 | Sale | $48.51 | 1,000 | 48,510 | 11,391 | Jan 05, 2016, 05:04 PM |
Yocher Robert E | SVP Regulatory Affairs | Dec 22, 2015 | Sale | $46.75 | 332 | 15,520 | 9,939 | Dec 23, 2015, 05:21 PM |
Schuermann James | SVP, Sales & Marketing | Dec 22, 2015 | Sale | $46.39 | 1,202 | 55,767 | 12,491 | Dec 23, 2015, 05:20 PM |
LaRose Jeffrey | Chief Scientific Officer | Dec 22, 2015 | Sale | $46.39 | 1,221 | 56,646 | 10,151 | Dec 23, 2015, 05:19 PM |
Knopf Lawrence J | General Counsel | Dec 22, 2015 | Sale | $46.44 | 721 | 33,482 | 15,511 | Dec 23, 2015, 05:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 22, 2015 | Sale | $46.30 | 4,324 | 200,205 | 75,580 | Dec 23, 2015, 05:18 PM |
Schuermann James | SVP, Sales & Marketing | Dec 21, 2015 | Sale | $46.54 | 553 | 25,737 | 11,093 | Dec 22, 2015, 05:24 PM |
Schuermann James | SVP, Sales & Marketing | Oct 01, 2015 | Sale | $53.01 | 1,000 | 53,012 | 10,330 | Oct 02, 2015, 08:17 PM |
Strong Mark | Senior VP, R&D and Quality | Oct 01, 2015 | Sale | $52.55 | 2,625 | 137,955 | 4,383 | Oct 02, 2015, 08:16 PM |
Leadley Katrin | Chief Medical Officer | Aug 26, 2015 | Sale | $80.02 | 3,750 | 300,092 | 301 | Aug 27, 2015, 05:04 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Aug 03, 2015 | Sale | $90.43 | 35,000 | 3,165,072 | 1,747,969 | Aug 04, 2015, 11:32 AM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Jul 31, 2015 | Sale | $92.00 | 75,000 | 6,900,000 | 1,757,969 | Aug 04, 2015, 11:32 AM |
Strong Mark | Senior VP, R&D and Quality | Jul 22, 2015 | Sale | $88.06 | 1,875 | 165,112 | 2,678 | Jul 23, 2015, 05:32 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Jul 10, 2015 | Sale | $73.36 | 3,125 | 229,259 | 14,246 | Jul 13, 2015, 05:17 PM |
Schuermann James | SVP, Sales & Marketing | Jul 01, 2015 | Sale | $72.78 | 1,000 | 72,780 | 10,980 | Jul 02, 2015, 05:04 PM |
Yocher Robert E | SVP Regulatory Affairs | Jun 24, 2015 | Sale | $77.41 | 829 | 64,173 | 9,171 | Jun 25, 2015, 05:04 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Apr 21, 2015 | Sale | $80.37 | 20,147 | 1,619,132 | 1,852,416 | Apr 21, 2015, 05:29 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Apr 21, 2015 | Sale | $80.61 | 1,800 | 145,098 | 1,853,116 | Apr 21, 2015, 05:29 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Apr 20, 2015 | Sale | $80.16 | 88,534 | 7,096,523 | 1,938,450 | Apr 21, 2015, 05:29 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Apr 17, 2015 | Sale | $81.57 | 62,786 | 5,121,570 | 1,993,736 | Apr 21, 2015, 05:29 PM |
Schuermann James | SVP, Sales & Marketing | Apr 01, 2015 | Sale | $86.34 | 1,000 | 86,339 | 12,080 | Apr 02, 2015, 05:07 PM |
Knopf Lawrence J | General Counsel | Mar 30, 2015 | Sale | $88.81 | 1,741 | 154,619 | 14,832 | Mar 30, 2015, 05:14 PM |
Yocher Robert E | SVP Regulatory Affairs | Feb 25, 2015 | Sale | $89.53 | 210 | 18,801 | 7,500 | Feb 26, 2015, 08:24 PM |
Strong Mark | Senior VP, R&D and Quality | Feb 25, 2015 | Sale | $89.56 | 395 | 35,376 | 1,196 | Feb 26, 2015, 08:23 PM |
Schuermann James | SVP, Sales & Marketing | Feb 25, 2015 | Sale | $89.56 | 574 | 51,407 | 12,980 | Feb 26, 2015, 08:22 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Feb 25, 2015 | Sale | $89.53 | 464 | 41,542 | 10,921 | Feb 26, 2015, 08:21 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 25, 2015 | Sale | $89.92 | 337 | 30,303 | 6,897 | Feb 26, 2015, 08:20 PM |
Knopf Lawrence J | General Counsel | Feb 25, 2015 | Sale | $89.52 | 399 | 35,718 | 11,123 | Feb 26, 2015, 08:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 25, 2015 | Sale | $89.58 | 1,842 | 165,006 | 70,670 | Feb 26, 2015, 08:18 PM |
Yocher Robert E | SVP Regulatory Affairs | Feb 09, 2015 | Sale | $86.68 | 309 | 26,783 | 7,178 | Feb 10, 2015, 05:06 PM |
Schuermann James | SVP, Sales & Marketing | Feb 09, 2015 | Sale | $86.45 | 523 | 45,213 | 11,842 | Feb 10, 2015, 05:06 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Feb 09, 2015 | Sale | $86.68 | 510 | 44,205 | 10,091 | Feb 10, 2015, 05:05 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 09, 2015 | Sale | $86.46 | 491 | 42,452 | 6,034 | Feb 10, 2015, 05:04 PM |
Knopf Lawrence J | General Counsel | Feb 09, 2015 | Sale | $86.47 | 510 | 44,100 | 10,322 | Feb 10, 2015, 05:03 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 09, 2015 | Sale | $86.58 | 1,698 | 147,014 | 67,112 | Feb 10, 2015, 05:02 PM |
Schuermann James | SVP, Sales & Marketing | Jan 02, 2015 | Option Exercise | $21.42 | 1,429 | 30,609 | 12,194 | Jan 05, 2015, 05:25 PM |
Schuermann James | SVP, Sales & Marketing | Jan 02, 2015 | Sale | $72.69 | 1,429 | 103,869 | 11,565 | Jan 05, 2015, 05:25 PM |
Yocher Robert E | SVP Regulatory Affairs | Dec 22, 2014 | Sale | $73.08 | 333 | 24,336 | 6,587 | Dec 23, 2014, 05:38 PM |
Schuermann James | SVP, Sales & Marketing | Dec 22, 2014 | Sale | $73.00 | 2,421 | 176,724 | 11,865 | Dec 23, 2014, 05:37 PM |
LaRose Jeffrey | Chief Scientific Officer | Dec 22, 2014 | Sale | $72.98 | 3,072 | 224,205 | 6,487 | Dec 23, 2014, 05:36 PM |
Knopf Lawrence J | General Counsel | Dec 22, 2014 | Sale | $72.92 | 722 | 52,648 | 9,632 | Dec 23, 2014, 05:35 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 22, 2014 | Sale | $73.01 | 7,028 | 513,110 | 68,038 | Dec 23, 2014, 05:33 PM |
Schuermann James | SVP, Sales & Marketing | Dec 01, 2014 | Option Exercise | $22.31 | 1,500 | 33,465 | 9,269 | Dec 02, 2014, 06:37 PM |
Schuermann James | SVP, Sales & Marketing | Dec 01, 2014 | Sale | $73.06 | 1,500 | 109,590 | 7,769 | Dec 02, 2014, 06:37 PM |
Thomas Robert Bain | Director | Nov 14, 2014 | Sale | $80.03 | 500 | 40,015 | 1,000 | Nov 17, 2014, 06:09 PM |
Thomas Robert Bain | Director | Nov 04, 2014 | Sale | $76.99 | 1,000 | 76,990 | 1,260 | Nov 06, 2014, 05:15 PM |
Schuermann James | SVP, Sales & Marketing | Nov 03, 2014 | Option Exercise | $23.08 | 1,500 | 34,620 | 9,269 | Nov 05, 2014, 02:56 PM |
Schuermann James | SVP, Sales & Marketing | Nov 03, 2014 | Sale | $76.36 | 1,500 | 114,540 | 7,769 | Nov 05, 2014, 02:56 PM |
Strong Mark | Senior VP, R&D and Quality | Oct 01, 2014 | Sale | $76.96 | 2,625 | 202,020 | 2,337 | Oct 01, 2014, 05:18 PM |
LaRose Jeffrey | Chief Scientific Officer | Sep 15, 2014 | Buy | $77.11 | 150 | 11,567 | 150 | Sep 17, 2014, 05:17 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sep 15, 2014 | Buy | $77.05 | 65,000 | 5,008,089 | 2,006,236 | Sep 16, 2014, 11:22 AM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sep 12, 2014 | Buy | $76.74 | 35,000 | 2,685,904 | 1,941,236 | Sep 16, 2014, 11:22 AM |
Knopf Lawrence J | General Counsel | Sep 10, 2014 | Sale | $78.37 | 465 | 36,442 | 8,654 | Sep 10, 2014, 05:20 PM |
LaRose Jeffrey | Chief Scientific Officer | Aug 19, 2014 | Option Exercise | $35.88 | 2,179 | 78,183 | 3,001 | Aug 20, 2014, 05:14 PM |
LaRose Jeffrey | Chief Scientific Officer | Aug 19, 2014 | Sale | $81.51 | 2,179 | 177,610 | 822 | Aug 20, 2014, 05:14 PM |
Thomas Robert Bain | Director | Aug 18, 2014 | Sale | $81.97 | 1,000 | 81,970 | 2,260 | Aug 19, 2014, 05:05 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Jul 10, 2014 | Sale | $84.76 | 2,070 | 175,453 | 9,101 | Jul 11, 2014, 05:14 PM |
Yocher Robert E | SVP, Regulatory & Quality | Jun 24, 2014 | Sale | $89.26 | 822 | 73,372 | 5,920 | Jun 25, 2014, 05:03 PM |
Thomas Robert Bain | Director | May 19, 2014 | Sale | $93.39 | 1,000 | 93,390 | 1,500 | May 20, 2014, 05:57 PM |
Thomas Robert Bain | Director | May 14, 2014 | Sale | $93.16 | 1,000 | 93,160 | 3,260 | May 16, 2014, 05:23 PM |
Thomas Robert Bain | Director | May 07, 2014 | Sale | $93.70 | 2,000 | 187,393 | 5,710 | May 09, 2014, 09:19 PM |
LaRose Jeffrey | Chief Scientific Officer | May 01, 2014 | Option Exercise | $35.72 | 2,179 | 77,834 | 3,001 | May 02, 2014, 05:48 PM |
LaRose Jeffrey | Chief Scientific Officer | May 01, 2014 | Sale | $89.96 | 2,179 | 196,024 | 2,701 | May 02, 2014, 05:48 PM |
LaRose Jeffrey | Chief Scientific Officer | Apr 01, 2014 | Option Exercise | $28.27 | 2,179 | 61,590 | 3,001 | Apr 02, 2014, 05:51 PM |
LaRose Jeffrey | Chief Scientific Officer | Apr 01, 2014 | Sale | $94.26 | 2,179 | 205,387 | 1,601 | Apr 02, 2014, 05:51 PM |
Knopf Lawrence J | General Counsel | Mar 31, 2014 | Sale | $91.15 | 1,744 | 158,970 | 7,920 | Mar 31, 2014, 05:33 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Mar 11, 2014 | Sale | $93.71 | 465 | 43,575 | 4,921 | Mar 12, 2014, 06:09 PM |
Schuermann James | SVP, Sales & Marketing | Mar 10, 2014 | Option Exercise | $23.79 | 2,000 | 47,580 | 9,769 | Mar 12, 2014, 05:35 PM |
Schuermann James | SVP, Sales & Marketing | Mar 10, 2014 | Sale | $94.22 | 2,000 | 188,440 | 7,769 | Mar 12, 2014, 05:35 PM |
LaRose Jeffrey | Chief Scientific Officer | Mar 10, 2014 | Sale | $93.56 | 5,018 | 469,484 | 822 | Mar 12, 2014, 05:28 PM |
Hathaway David R | Chief Medical Officer | Mar 11, 2014 | Option Exercise | $18.02 | 2,812 | 50,672 | 2,812 | Mar 12, 2014, 05:24 PM |
Hathaway David R | Chief Medical Officer | Mar 10, 2014 | Option Exercise | $18.08 | 299 | 5,406 | 1,601 | Mar 12, 2014, 05:24 PM |
Hathaway David R | Chief Medical Officer | Mar 11, 2014 | Sale | $95.00 | 2,812 | 267,140 | 0 | Mar 12, 2014, 05:24 PM |
Hathaway David R | Chief Medical Officer | Mar 10, 2014 | Sale | $95.00 | 1,601 | 152,095 | 0 | Mar 12, 2014, 05:24 PM |
LaRose Jeffrey | Chief Scientific Officer | Mar 03, 2014 | Option Exercise | $15.61 | 2,179 | 34,014 | 8,019 | Mar 04, 2014, 05:59 PM |
LaRose Jeffrey | Chief Scientific Officer | Mar 03, 2014 | Sale | $93.15 | 2,179 | 202,975 | 6,366 | Mar 04, 2014, 05:59 PM |
Thomas Robert Bain | Director | Dec 18, 2013 | Sale | $92.27 | 6,942 | 640,538 | 0 | Feb 14, 2014, 05:06 PM |
Thomas Robert Bain | Director | May 23, 2013 | Sale | $91.90 | 2,300 | 211,370 | 6,370 | Feb 14, 2014, 05:05 PM |
Thomas Robert Bain | Director | May 25, 2012 | Sale | $79.29 | 5,000 | 396,450 | 16,370 | Feb 14, 2014, 05:03 PM |
Thomas Robert Bain | Director | Sep 06, 2011 | Sale | $60.35 | 5,000 | 301,750 | 5,714 | Feb 14, 2014, 05:02 PM |
Yocher Robert E | SVP, Regulatory & Quality | Feb 10, 2014 | Sale | $94.57 | 428 | 40,476 | 4,242 | Feb 11, 2014, 06:07 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 10, 2014 | Sale | $94.58 | 685 | 64,787 | 5,840 | Feb 11, 2014, 06:07 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 10, 2014 | Sale | $94.57 | 2,428 | 229,616 | 56,126 | Feb 11, 2014, 06:07 PM |
Schuermann James | SVP, Sales & Marketing | Feb 10, 2014 | Sale | $94.72 | 810 | 76,723 | 7,769 | Feb 11, 2014, 06:07 PM |
Knopf Lawrence J | General Counsel | Feb 10, 2014 | Sale | $94.61 | 714 | 67,552 | 4,213 | Feb 11, 2014, 06:07 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Feb 10, 2014 | Sale | $94.62 | 714 | 67,559 | 3,986 | Feb 11, 2014, 06:07 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 03, 2014 | Option Exercise | $15.31 | 2,179 | 33,360 | 7,104 | Feb 04, 2014, 05:47 PM |
LaRose Jeffrey | Chief Scientific Officer | Feb 03, 2014 | Sale | $98.48 | 2,179 | 214,578 | 5,325 | Feb 04, 2014, 05:47 PM |
LaRose Jeffrey | Chief Scientific Officer | Jan 07, 2014 | Sale | $100.00 | 15,342 | 1,534,200 | 4,925 | Jan 07, 2014, 05:22 PM |
Knopf Lawrence J | General Counsel | Jan 06, 2014 | Sale | $97.50 | 861 | 83,948 | 3,527 | Jan 07, 2014, 05:07 PM |
Harrison Seth Loring | Director | Jan 06, 2014 | Sale | $99.29 | 7,909 | 785,285 | 132,393 | Jan 07, 2014, 05:06 PM |
Yocher Robert E | SVP, Regulatory & Quality | Dec 23, 2013 | Sale | $90.96 | 482 | 43,843 | 3,870 | Dec 24, 2013, 03:19 PM |
Schuermann James | SVP, Sales & Marketing | Dec 23, 2013 | Sale | $91.06 | 1,204 | 109,637 | 6,980 | Dec 24, 2013, 03:17 PM |
Schuermann James | SVP, Sales & Marketing | Dec 20, 2013 | Sale | $91.71 | 1,405 | 128,848 | 5,883 | Dec 24, 2013, 03:17 PM |
LaRose Jeffrey | Chief Scientific Officer | Dec 20, 2013 | Sale | $91.75 | 1,199 | 110,002 | 17,965 | Dec 24, 2013, 03:15 PM |
LaRose Jeffrey | Chief Scientific Officer | Dec 23, 2013 | Sale | $91.17 | 1,873 | 170,762 | 20,467 | Dec 24, 2013, 03:15 PM |
Knopf Lawrence J | General Counsel | Dec 23, 2013 | Sale | $90.99 | 723 | 65,786 | 4,388 | Dec 24, 2013, 03:09 PM |
Hathaway David R | Chief Medical Officer | Dec 23, 2013 | Sale | $91.03 | 602 | 54,800 | 1,302 | Dec 24, 2013, 03:07 PM |
Hathaway David R | Chief Medical Officer | Dec 20, 2013 | Sale | $91.71 | 609 | 55,851 | 774 | Dec 24, 2013, 03:07 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 23, 2013 | Sale | $91.13 | 4,333 | 394,883 | 53,979 | Dec 24, 2013, 03:05 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 20, 2013 | Sale | $91.75 | 2,703 | 248,013 | 49,163 | Dec 24, 2013, 03:05 PM |
Thomas Robert Bain | Director | Dec 06, 2013 | Sale | $95.29 | 3,000 | 285,870 | 5,510 | Dec 10, 2013, 05:16 PM |
Thomas Robert Bain | Director | Dec 04, 2013 | Sale | $95.54 | 2,500 | 238,850 | 4,800 | Dec 06, 2013, 02:37 PM |
LaRose Jeffrey | Chief Scientific Officer | Dec 02, 2013 | Option Exercise | $15.94 | 2,179 | 34,733 | 18,343 | Dec 03, 2013, 05:04 PM |
LaRose Jeffrey | Chief Scientific Officer | Dec 02, 2013 | Sale | $96.39 | 2,179 | 210,034 | 16,164 | Dec 03, 2013, 05:04 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 02, 2013 | Option Exercise | $35.06 | 13,000 | 455,780 | 58,977 | Dec 03, 2013, 05:03 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 02, 2013 | Sale | $95.51 | 13,000 | 1,241,614 | 51,496 | Dec 03, 2013, 05:03 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Nov 15, 2013 | Option Exercise | $35.92 | 10,000 | 359,200 | 55,977 | Nov 18, 2013, 05:23 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Nov 15, 2013 | Sale | $90.00 | 10,000 | 900,000 | 45,977 | Nov 18, 2013, 05:23 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Nov 07, 2013 | Option Exercise | $36.64 | 3,000 | 109,920 | 53,977 | Nov 08, 2013, 04:53 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Nov 07, 2013 | Sale | $83.06 | 8,000 | 664,503 | 50,977 | Nov 08, 2013, 04:53 PM |
LaRose Jeffrey | Chief Scientific Officer | Nov 07, 2013 | Option Exercise | $16.65 | 2,179 | 36,280 | 18,343 | Nov 08, 2013, 04:52 PM |
LaRose Jeffrey | Chief Scientific Officer | Nov 07, 2013 | Sale | $85.44 | 2,179 | 186,174 | 16,164 | Nov 08, 2013, 04:52 PM |
LaRose Jeffrey | Chief Scientific Officer | Sep 03, 2013 | Option Exercise | $15.70 | 2,179 | 34,210 | 18,343 | Sep 04, 2013, 05:33 PM |
LaRose Jeffrey | Chief Scientific Officer | Sep 03, 2013 | Sale | $78.59 | 2,179 | 171,249 | 16,364 | Sep 04, 2013, 05:33 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 03, 2013 | Option Exercise | $34.54 | 3,000 | 103,620 | 63,977 | Sep 04, 2013, 05:33 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 03, 2013 | Sale | $78.08 | 8,000 | 624,651 | 57,437 | Sep 04, 2013, 05:33 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 01, 2013 | Option Exercise | $34.70 | 13,000 | 451,100 | 78,977 | Aug 02, 2013, 05:29 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 01, 2013 | Sale | $94.74 | 18,000 | 1,705,320 | 60,977 | Aug 02, 2013, 05:29 PM |
LaRose Jeffrey | Chief Scientific Officer | Aug 01, 2013 | Option Exercise | $15.77 | 2,179 | 34,363 | 18,343 | Aug 02, 2013, 05:28 PM |
LaRose Jeffrey | Chief Scientific Officer | Aug 01, 2013 | Sale | $93.11 | 2,179 | 202,888 | 16,288 | Aug 02, 2013, 05:28 PM |
Schuermann James | SVP, Sales & Marketing | Aug 01, 2013 | Sale | $93.07 | 1,000 | 93,070 | 4,171 | Aug 02, 2013, 05:27 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 25, 2013 | Option Exercise | $35.53 | 12,636 | 448,957 | 83,613 | Jul 29, 2013, 06:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 29, 2013 | Option Exercise | $35.63 | 2,530 | 90,144 | 73,507 | Jul 29, 2013, 06:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 26, 2013 | Option Exercise | $35.32 | 12,834 | 453,297 | 83,811 | Jul 29, 2013, 06:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 25, 2013 | Sale | $93.57 | 12,636 | 1,182,293 | 75,030 | Jul 29, 2013, 06:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 29, 2013 | Sale | $92.14 | 7,530 | 693,846 | 66,413 | Jul 29, 2013, 06:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 26, 2013 | Sale | $92.83 | 12,834 | 1,191,323 | 75,152 | Jul 29, 2013, 06:19 PM |
MCAREE PETER F | SVP, CFO and Treasurer | Jul 10, 2013 | Sale | $93.58 | 2,950 | 276,061 | 3,300 | Jul 11, 2013, 05:33 PM |
LaRose Jeffrey | Chief Scientific Officer | Jul 01, 2013 | Option Exercise | $15.98 | 2,179 | 34,820 | 18,343 | Jul 02, 2013, 05:40 PM |
LaRose Jeffrey | Chief Scientific Officer | Jul 01, 2013 | Sale | $95.85 | 2,179 | 208,866 | 16,988 | Jul 02, 2013, 05:40 PM |
Harrison Seth Loring | Director | Jul 01, 2013 | Sale | $95.57 | 13,118 | 1,253,734 | 146,302 | Jul 02, 2013, 05:38 PM |
Knopf Lawrence J | General Counsel | Jun 26, 2013 | Sale | $95.00 | 992 | 94,240 | 3,611 | Jun 27, 2013, 05:33 PM |
Yocher Robert E | SVP, Regulatory & Quality | Jun 25, 2013 | Sale | $94.25 | 1,162 | 109,519 | 3,352 | Jun 25, 2013, 05:40 PM |
LaRose Jeffrey | Chief Scientific Officer | Jun 17, 2013 | Option Exercise | $16.74 | 2,179 | 36,476 | 18,343 | Jun 19, 2013, 06:11 PM |
LaRose Jeffrey | Chief Scientific Officer | Jun 17, 2013 | Sale | $91.14 | 2,179 | 198,594 | 16,164 | Jun 19, 2013, 06:11 PM |
Thomas Robert Bain | Director | Jun 06, 2013 | Sale | $90.44 | 2,656 | 240,200 | 7,300 | Jun 07, 2013, 05:30 PM |
Thomas Robert Bain | Director | May 30, 2013 | Sale | $94.05 | 57 | 5,361 | 8,228 | May 30, 2013, 05:48 PM |
Thomas Robert Bain | Director | May 29, 2013 | Sale | $92.86 | 714 | 66,300 | 8,299 | May 30, 2013, 05:48 PM |
Thomas Robert Bain | Director | May 28, 2013 | Sale | $91.07 | 286 | 26,046 | 8,999 | May 30, 2013, 05:48 PM |
Thomas Robert Bain | Director | May 28, 2013 | Sale | $94.71 | 2,500 | 236,781 | 10,810 | May 30, 2013, 05:48 PM |
Hathaway David R | Chief Medical Officer | May 28, 2013 | Option Exercise | $19.22 | 4,491 | 86,317 | 5,934 | May 30, 2013, 05:47 PM |
Hathaway David R | Chief Medical Officer | May 28, 2013 | Sale | $95.05 | 5,934 | 564,027 | 0 | May 30, 2013, 05:47 PM |
Hathaway David R | Chief Medical Officer | May 22, 2013 | Option Exercise | $19.55 | 2,400 | 46,920 | 3,843 | May 22, 2013, 08:41 PM |
Hathaway David R | Chief Medical Officer | May 21, 2013 | Option Exercise | $19.51 | 17,140 | 334,401 | 18,583 | May 22, 2013, 08:41 PM |
Hathaway David R | Chief Medical Officer | May 20, 2013 | Option Exercise | $19.40 | 10,000 | 194,000 | 11,443 | May 22, 2013, 08:41 PM |
Hathaway David R | Chief Medical Officer | May 22, 2013 | Sale | $95.15 | 2,400 | 228,360 | 1,443 | May 22, 2013, 08:41 PM |
Hathaway David R | Chief Medical Officer | May 21, 2013 | Sale | $95.76 | 17,140 | 1,641,378 | 5,741 | May 22, 2013, 08:41 PM |
Hathaway David R | Chief Medical Officer | May 20, 2013 | Sale | $97.72 | 10,000 | 977,236 | 3,243 | May 22, 2013, 08:41 PM |
Thomas Robert Bain | Director | May 21, 2013 | Sale | $97.69 | 200 | 19,538 | 8,670 | May 22, 2013, 08:33 PM |
Thomas Robert Bain | Director | May 20, 2013 | Sale | $98.41 | 3,929 | 386,645 | 10,000 | May 22, 2013, 08:33 PM |
Thomas Robert Bain | Director | May 20, 2013 | Sale | $97.82 | 2,500 | 244,539 | 11,582 | May 22, 2013, 08:33 PM |
Wade Denis Newell | Director | May 20, 2013 | Sale | $99.00 | 4,000 | 396,000 | 4,966 | May 22, 2013, 05:49 PM |
Knopf Lawrence J | General Counsel | May 20, 2013 | Sale | $97.72 | 2,000 | 195,440 | 4,603 | May 22, 2013, 05:44 PM |
LaRose Jeffrey | Chief Scientific Officer | May 20, 2013 | Sale | $97.79 | 9,574 | 936,261 | 18,267 | May 22, 2013, 05:42 PM |
Schuermann James | SVP, Sales & Marketing | May 01, 2013 | Sale | $97.20 | 1,000 | 97,200 | 5,171 | May 03, 2013, 06:24 PM |
Knopf Lawrence J | General Counsel | Mar 28, 2013 | Sale | $88.54 | 2,500 | 221,358 | 6,773 | Mar 28, 2013, 06:14 PM |
Schuermann James | SVP, Sales & Marketing | Feb 01, 2013 | Sale | $90.59 | 1,000 | 90,590 | 6,671 | Feb 01, 2013, 05:39 PM |
Yocher Robert E | SVP, Regulatory & Quality | Dec 21, 2012 | Sale | $82.04 | 426 | 34,950 | 2,277 | Dec 26, 2012, 08:36 AM |
Schuermann James | SVP, Sales & Marketing | Dec 21, 2012 | Sale | $82.05 | 1,064 | 87,300 | 7,829 | Dec 26, 2012, 08:35 AM |
Schuermann James | SVP, Sales & Marketing | Dec 20, 2012 | Sale | $82.09 | 532 | 43,672 | 5,735 | Dec 26, 2012, 08:35 AM |
LaRose Jeffrey | Chief Scientific Officer | Dec 20, 2012 | Sale | $82.09 | 1,042 | 85,538 | 22,990 | Dec 26, 2012, 08:34 AM |
LaRose Jeffrey | Chief Scientific Officer | Dec 21, 2012 | Sale | $82.05 | 1,627 | 133,493 | 26,743 | Dec 26, 2012, 08:34 AM |
Knopf Lawrence J | General Counsel | Dec 21, 2012 | Sale | $82.04 | 639 | 52,425 | 4,248 | Dec 26, 2012, 08:34 AM |
Hathaway David R | Chief Medical Officer | Dec 21, 2012 | Sale | $82.04 | 532 | 43,647 | 1,772 | Dec 26, 2012, 08:33 AM |
Hathaway David R | Chief Medical Officer | Dec 20, 2012 | Sale | $82.09 | 537 | 44,082 | 725 | Dec 26, 2012, 08:33 AM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 21, 2012 | Sale | $82.04 | 3,829 | 314,140 | 73,343 | Dec 26, 2012, 08:32 AM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 20, 2012 | Sale | $82.09 | 2,388 | 196,031 | 65,806 | Dec 26, 2012, 08:32 AM |
Farrell Lauren | VP, Finance | Dec 21, 2012 | Sale | $82.04 | 405 | 33,225 | 2,278 | Dec 26, 2012, 08:31 AM |
Farrell Lauren | VP, Finance | Dec 20, 2012 | Sale | $82.08 | 243 | 19,945 | 1,183 | Dec 26, 2012, 08:31 AM |
Harrison Seth Loring | Director | Dec 14, 2012 | Sale | $81.01 | 75,922 | 6,150,531 | 750,000 | Dec 18, 2012, 07:04 PM |
Wade Denis Newell | Director | Dec 13, 2012 | Sale | $81.00 | 2,163 | 175,203 | 8,966 | Dec 13, 2012, 08:56 PM |
Wade Denis Newell | Director | Dec 12, 2012 | Sale | $82.50 | 337 | 27,803 | 11,129 | Dec 13, 2012, 08:56 PM |
Harrison Seth Loring | Director | Dec 13, 2012 | Sale | $81.28 | 108,571 | 8,825,061 | 825,422 | Dec 13, 2012, 08:53 PM |
Harrison Seth Loring | Director | Dec 12, 2012 | Sale | $81.82 | 11,480 | 939,294 | 933,493 | Dec 13, 2012, 08:53 PM |
Harrison Seth Loring | Director | Dec 11, 2012 | Sale | $82.18 | 55,358 | 4,549,320 | 944,973 | Dec 13, 2012, 08:53 PM |
Hathaway David R | Chief Medical Officer | Dec 13, 2012 | Sale | $81.10 | 5,640 | 457,404 | 0 | Dec 13, 2012, 08:49 PM |
Hathaway David R | Chief Medical Officer | Dec 12, 2012 | Sale | $81.81 | 6,000 | 490,860 | 5,640 | Dec 13, 2012, 08:49 PM |
Hathaway David R | Chief Medical Officer | Dec 11, 2012 | Sale | $82.17 | 6,000 | 493,020 | 11,640 | Dec 13, 2012, 08:49 PM |
Harrison Seth Loring | Director | Dec 10, 2012 | Sale | $83.03 | 25,500 | 2,117,265 | 1,000,331 | Dec 11, 2012, 05:03 PM |
Harrison Seth Loring | Director | Dec 07, 2012 | Sale | $80.26 | 48,130 | 3,862,886 | 1,071,961 | Dec 11, 2012, 05:03 PM |
Thomas Robert Bain | Director | Dec 03, 2012 | Sale | $80.60 | 1,400 | 112,840 | 16,277 | Dec 05, 2012, 06:59 PM |
Thomas Robert Bain | Director | Dec 04, 2012 | Sale | $80.36 | 3,600 | 289,296 | 12,677 | Dec 05, 2012, 06:59 PM |
Schuermann James | SVP, Sales & Marketing | Dec 03, 2012 | Sale | $81.73 | 2,500 | 204,315 | 6,517 | Dec 04, 2012, 07:26 PM |
LaRose Jeffrey | Chief Scientific Officer | Dec 03, 2012 | Sale | $80.26 | 1,413 | 113,407 | 21,232 | Dec 04, 2012, 07:22 PM |
Schuermann James | SVP, Sales & Marketing | Nov 21, 2012 | Sale | $83.97 | 800 | 67,175 | 8,270 | Nov 23, 2012, 04:57 PM |
LaRose Jeffrey | Chief Scientific Officer | Nov 21, 2012 | Sale | $83.97 | 909 | 76,327 | 23,500 | Nov 23, 2012, 04:52 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Nov 21, 2012 | Sale | $83.97 | 3,817 | 320,512 | 66,176 | Nov 23, 2012, 04:50 PM |
Farrell Lauren | VP, Finance | Nov 21, 2012 | Sale | $85.98 | 536 | 46,087 | 1,201 | Nov 23, 2012, 04:47 PM |
Schuermann James | SVP, Sales & Marketing | Nov 01, 2012 | Sale | $84.01 | 1,000 | 84,010 | 6,531 | Nov 02, 2012, 07:07 PM |
Farrell Lauren | VP, Finance | Sep 18, 2012 | Sale | $92.43 | 69 | 6,378 | 714 | Sep 18, 2012, 08:13 PM |
Farrell Lauren | VP, Finance | Sep 17, 2012 | Sale | $92.38 | 255 | 23,557 | 965 | Sep 18, 2012, 08:13 PM |
Schuermann James | SVP, Sales & Marketing | Sep 18, 2012 | Sale | $92.44 | 915 | 84,584 | 8,041 | Sep 18, 2012, 08:09 PM |
Schuermann James | SVP, Sales & Marketing | Sep 17, 2012 | Sale | $92.38 | 3,339 | 308,461 | 11,325 | Sep 18, 2012, 08:09 PM |
LaRose Jeffrey | Chief Scientific Officer | Sep 17, 2012 | Sale | $92.38 | 4,377 | 404,347 | 26,207 | Sep 18, 2012, 08:07 PM |
LaRose Jeffrey | Chief Scientific Officer | Sep 18, 2012 | Sale | $92.44 | 1,200 | 110,930 | 21,901 | Sep 18, 2012, 08:07 PM |
Hathaway David R | Chief Medical Officer | Sep 18, 2012 | Sale | $92.44 | 916 | 84,676 | 18,150 | Sep 18, 2012, 08:06 PM |
Hathaway David R | Chief Medical Officer | Sep 17, 2012 | Sale | $92.38 | 3,338 | 308,364 | 21,435 | Sep 18, 2012, 08:06 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 18, 2012 | Option Exercise | $40.48 | 7,500 | 303,600 | 65,327 | Sep 18, 2012, 08:04 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 18, 2012 | Sale | $92.71 | 11,162 | 1,034,785 | 63,404 | Sep 18, 2012, 08:04 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 17, 2012 | Sale | $92.38 | 13,352 | 1,233,476 | 73,005 | Sep 18, 2012, 08:04 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 28, 2012 | Option Exercise | $40.01 | 3,146 | 125,871 | 37,987 | Aug 28, 2012, 06:37 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 24, 2012 | Option Exercise | $40.38 | 1,854 | 74,865 | 36,695 | Aug 28, 2012, 06:37 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 28, 2012 | Sale | $90.24 | 3,146 | 283,895 | 34,841 | Aug 28, 2012, 06:37 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 24, 2012 | Sale | $90.09 | 1,854 | 167,027 | 34,841 | Aug 28, 2012, 06:37 PM |
Thomas Robert Bain | Director | Aug 23, 2012 | Sale | $88.80 | 5,000 | 444,000 | 17,677 | Aug 24, 2012, 05:44 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 17, 2012 | Option Exercise | $40.41 | 2,500 | 101,025 | 37,341 | Aug 20, 2012, 06:49 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Aug 17, 2012 | Sale | $88.98 | 2,500 | 222,450 | 34,841 | Aug 20, 2012, 06:49 PM |
Schuermann James | SVP, Sales & Marketing | Aug 01, 2012 | Sale | $89.04 | 1,000 | 89,040 | 1,785 | Aug 02, 2012, 06:51 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 17, 2012 | Option Exercise | $39.38 | 7,500 | 295,350 | 42,341 | Jul 18, 2012, 07:27 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 17, 2012 | Sale | $90.32 | 7,500 | 677,405 | 35,316 | Jul 18, 2012, 07:27 PM |
Harrison Seth Loring | Director | Jul 16, 2012 | Sale | $90.21 | 17,460 | 1,575,067 | 54,951 | Jul 16, 2012, 07:00 PM |
Harrison Seth Loring | Director | Jul 13, 2012 | Sale | $90.00 | 8,279 | 745,110 | 72,411 | Jul 16, 2012, 07:00 PM |
Harrison Seth Loring | Director | Jul 12, 2012 | Sale | $90.00 | 175 | 15,750 | 80,690 | Jul 16, 2012, 07:00 PM |
Harrison Seth Loring | Director | Jul 16, 2012 | Sale | $90.21 | 1,941 | 175,098 | 6,004 | Jul 16, 2012, 07:00 PM |
Harrison Seth Loring | Director | Jul 13, 2012 | Sale | $90.00 | 920 | 82,800 | 7,945 | Jul 16, 2012, 07:00 PM |
Harrison Seth Loring | Director | Jul 12, 2012 | Sale | $90.00 | 19 | 1,710 | 8,865 | Jul 16, 2012, 07:00 PM |
Harrison Seth Loring | Director | Jul 02, 2012 | Sale | $90.00 | 630 | 56,700 | 81,338 | Jul 05, 2012, 06:52 PM |
Harrison Seth Loring | Director | Jul 03, 2012 | Sale | $90.00 | 52 | 4,680 | 8,884 | Jul 05, 2012, 06:52 PM |
Harrison Seth Loring | Director | Jul 02, 2012 | Sale | $90.00 | 70 | 6,300 | 8,936 | Jul 05, 2012, 06:52 PM |
Harrison Seth Loring | Director | Jul 03, 2012 | Sale | $90.00 | 473 | 42,570 | 80,865 | Jul 05, 2012, 06:52 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 02, 2012 | Option Exercise | $39.41 | 5,000 | 197,050 | 39,841 | Jul 03, 2012, 06:11 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jul 02, 2012 | Sale | $90.00 | 5,000 | 450,000 | 34,841 | Jul 03, 2012, 06:11 PM |
Schuermann James | VP, Sales & Marketing | Jul 02, 2012 | Sale | $90.00 | 1,000 | 90,000 | 2,785 | Jul 03, 2012, 06:07 PM |
Yocher Robert E | SVP, Regulatory & Quality | Jun 25, 2012 | Sale | $86.41 | 1,060 | 91,595 | 1,440 | Jun 26, 2012, 06:41 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jun 18, 2012 | Option Exercise | $38.81 | 2,500 | 97,025 | 37,341 | Jun 25, 2012, 06:27 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jun 18, 2012 | Sale | $85.81 | 2,500 | 214,525 | 34,841 | Jun 25, 2012, 06:27 PM |
Thomas Robert Bain | Director | Jun 13, 2012 | Sale | $85.24 | 714 | 60,861 | 10,714 | Jun 14, 2012, 06:13 PM |
Thomas Robert Bain | Director | Jun 12, 2012 | Sale | $85.61 | 5,000 | 428,050 | 11,370 | Jun 14, 2012, 06:13 PM |
Schuermann James | VP, Sales & Marketing | Jun 08, 2012 | Sale | $85.00 | 1,000 | 85,000 | 3,785 | Jun 11, 2012, 06:20 PM |
Stockman Robert Bernard | Director | Jun 07, 2012 | Sale | $82.61 | 3,025 | 249,895 | 13,677 | Jun 11, 2012, 06:03 PM |
Thomas Robert Bain | Director | May 25, 2012 | Sale | $78.54 | 428 | 33,615 | 0 | May 25, 2012, 09:45 PM |
Thomas Robert Bain | Director | May 23, 2012 | Sale | $78.34 | 957 | 74,971 | 11,428 | May 25, 2012, 09:45 PM |
LaRose Jeffrey | Chief Scientifc Officer | May 21, 2012 | Sale | $79.83 | 1,322 | 105,535 | 11,809 | May 23, 2012, 06:56 PM |
Thomas Robert Bain | Director | May 18, 2012 | Sale | $78.88 | 6,429 | 507,112 | 16,370 | May 22, 2012, 06:33 PM |
Godshall Douglas Evan | President & Chief Exec Officer | May 17, 2012 | Option Exercise | $38.20 | 2,500 | 95,500 | 37,341 | May 17, 2012, 04:35 PM |
Godshall Douglas Evan | President & Chief Exec Officer | May 17, 2012 | Sale | $80.23 | 2,500 | 200,575 | 34,841 | May 17, 2012, 04:35 PM |
Thomas Robert Bain | Director | May 15, 2012 | Sale | $80.73 | 5,000 | 403,650 | 26,370 | May 17, 2012, 04:32 PM |
Thomas Robert Bain | Director | May 16, 2012 | Sale | $80.00 | 5,000 | 400,000 | 21,370 | May 17, 2012, 04:32 PM |
Farrell Lauren | VP, Finance | May 11, 2012 | Sale | $81.73 | 475 | 38,822 | 0 | May 14, 2012, 05:06 PM |
Schuermann James | VP, Sales & Marketing | May 09, 2012 | Sale | $77.12 | 313 | 24,137 | 4,889 | May 10, 2012, 07:31 PM |
LaRose Jeffrey | Chief Scientifc Officer | May 09, 2012 | Sale | $77.12 | 820 | 63,236 | 13,405 | May 10, 2012, 07:30 PM |
Godshall Douglas Evan | President & Chief Exec Officer | May 09, 2012 | Sale | $77.12 | 3,445 | 265,668 | 35,992 | May 10, 2012, 07:29 PM |
Farrell Lauren | VP, Finance | May 09, 2012 | Sale | $77.12 | 239 | 18,431 | 554 | May 10, 2012, 07:27 PM |
Schuermann James | VP, Sales & Marketing | May 01, 2012 | Sale | $79.11 | 2,500 | 197,772 | 6,184 | May 01, 2012, 06:08 PM |
Farrell Lauren | VP, Finance | Apr 26, 2012 | Option Exercise | $24.96 | 1,286 | 32,096 | 1,286 | Apr 30, 2012, 06:50 PM |
Farrell Lauren | VP, Finance | Apr 26, 2012 | Sale | $78.00 | 1,286 | 100,308 | 0 | Apr 30, 2012, 06:50 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Apr 26, 2012 | Option Exercise | $39.94 | 2,500 | 99,850 | 32,929 | Apr 30, 2012, 06:49 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Apr 26, 2012 | Sale | $77.59 | 2,500 | 193,975 | 30,429 | Apr 30, 2012, 06:49 PM |
Harrison Seth Loring | Director | Apr 26, 2012 | Sale | $77.27 | 3,002 | 231,951 | 9,266 | Apr 30, 2012, 06:46 PM |
Harrison Seth Loring | Director | Apr 26, 2012 | Sale | $77.27 | 27,017 | 2,087,486 | 83,725 | Apr 30, 2012, 06:46 PM |
Knopf Lawrence J | General Counsel | Mar 28, 2012 | Sale | $67.51 | 2,258 | 152,438 | 4,292 | Mar 30, 2012, 05:02 PM |
Thomas Robert Bain | Director | Mar 06, 2012 | Sale | $70.33 | 5,999 | 421,909 | 31,370 | Mar 08, 2012, 05:51 PM |
Wade Denis Newell | Director | Feb 28, 2012 | Sale | $74.50 | 6,000 | 447,000 | 11,466 | Feb 29, 2012, 09:04 PM |
Wade Denis Newell | Director | Feb 27, 2012 | Sale | $73.75 | 12,000 | 885,000 | 23,466 | Feb 29, 2012, 09:03 PM |
Wade Denis Newell | Director | Feb 24, 2012 | Sale | $73.50 | 6,000 | 441,000 | 29,466 | Feb 29, 2012, 09:03 PM |
Wade Denis Newell | Director | Feb 22, 2012 | Sale | $74.00 | 6,000 | 444,000 | 35,466 | Feb 29, 2012, 08:59 PM |
Thomas Robert Bain | Director | Feb 27, 2012 | Sale | $73.00 | 124 | 9,052 | 5,714 | Feb 29, 2012, 08:14 PM |
Wade Denis Newell | Director | Feb 28, 2012 | Sale | $74.50 | 6,000 | 447,000 | 17,466 | Feb 28, 2012, 06:56 PM |
Thomas Robert Bain | Director | Feb 27, 2012 | Sale | $72.95 | 471 | 34,359 | 13,815 | Feb 27, 2012, 08:51 PM |
Thomas Robert Bain | Director | Feb 24, 2012 | Sale | $74.00 | 1,376 | 101,824 | 5,838 | Feb 27, 2012, 08:51 PM |
Thomas Robert Bain | Director | Feb 23, 2012 | Sale | $74.00 | 1,000 | 74,000 | 7,214 | Feb 27, 2012, 08:51 PM |
Wade Denis Newell | Director | Feb 24, 2012 | Sale | $73.50 | 6,000 | 441,000 | 35,466 | Feb 27, 2012, 08:49 PM |
Wade Denis Newell | Director | Feb 27, 2012 | Sale | $73.75 | 12,000 | 885,000 | 29,466 | Feb 27, 2012, 08:49 PM |
Thomas Robert Bain | Director | Feb 21, 2012 | Sale | $73.59 | 571 | 42,022 | 785 | Feb 23, 2012, 07:17 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 17, 2012 | Option Exercise | $41.19 | 1,620 | 66,728 | 34,347 | Feb 17, 2012, 07:10 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 16, 2012 | Option Exercise | $41.29 | 2,500 | 103,225 | 35,227 | Feb 17, 2012, 07:10 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 17, 2012 | Sale | $74.94 | 3,918 | 293,610 | 33,327 | Feb 17, 2012, 07:10 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 16, 2012 | Sale | $75.00 | 2,500 | 187,500 | 32,727 | Feb 17, 2012, 07:10 PM |
Farrell Lauren | VP, Finance | Feb 16, 2012 | Sale | $75.00 | 600 | 45,000 | 0 | Feb 17, 2012, 06:47 PM |
Schuermann James | VP, Sales & Marketing | Feb 01, 2012 | Sale | $69.13 | 1,000 | 69,130 | 6,884 | Feb 01, 2012, 05:54 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jan 31, 2012 | Sale | $70.07 | 5,000 | 350,350 | 32,727 | Feb 01, 2012, 05:52 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jan 06, 2012 | Sale | $70.51 | 3,850 | 271,449 | 38,402 | Jan 06, 2012, 06:03 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jan 05, 2012 | Sale | $70.08 | 1,150 | 80,592 | 41,577 | Jan 06, 2012, 06:03 PM |
Farrell Lauren | VP, Finance | Jan 06, 2012 | Sale | $72.00 | 499 | 35,928 | 600 | Jan 06, 2012, 05:59 PM |
Schuermann James | VP, Sales & Marketing | Jan 05, 2012 | Sale | $70.00 | 808 | 56,560 | 7,884 | Jan 05, 2012, 06:58 PM |
Schuermann James | VP, Sales & Marketing | Jan 03, 2012 | Sale | $70.00 | 192 | 13,440 | 8,692 | Jan 05, 2012, 06:58 PM |
Farrell Lauren | VP, Finance | Jan 03, 2012 | Sale | $70.00 | 672 | 47,040 | 1,099 | Jan 05, 2012, 06:40 PM |
Schuermann James | VP, Sales & Marketing | Dec 20, 2011 | Sale | $68.25 | 548 | 37,404 | 9,017 | Dec 22, 2011, 06:41 PM |
LaRose Jeffrey | Chief Scientifc Officer | Dec 20, 2011 | Sale | $68.26 | 1,072 | 73,177 | 12,069 | Dec 22, 2011, 06:37 PM |
Hathaway David R | Chief Medical Officer | Dec 20, 2011 | Sale | $68.26 | 554 | 37,817 | 12,028 | Dec 22, 2011, 06:30 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 20, 2011 | Sale | $68.26 | 2,461 | 167,994 | 43,325 | Dec 22, 2011, 06:23 PM |
Farrell Lauren | VP, Finance | Dec 20, 2011 | Sale | $68.25 | 251 | 17,132 | 1,832 | Dec 22, 2011, 06:20 PM |
McIntyre David | CFO & COO | Dec 19, 2011 | Option Exercise | $38.41 | 5,714 | 219,475 | 5,714 | Dec 21, 2011, 06:23 PM |
McIntyre David | CFO & COO | Dec 20, 2011 | Sale | $68.19 | 3,125 | 213,082 | 424 | Dec 21, 2011, 06:23 PM |
McIntyre David | CFO & COO | Dec 19, 2011 | Sale | $68.50 | 7,337 | 502,551 | 1,600 | Dec 21, 2011, 06:23 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 13, 2011 | Sale | $70.00 | 800 | 56,000 | 39,575 | Dec 13, 2011, 07:02 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Dec 09, 2011 | Sale | $70.09 | 6,505 | 455,935 | 40,375 | Dec 13, 2011, 07:02 PM |
Schuermann James | VP, Sales & Marketing | Dec 07, 2011 | Sale | $68.61 | 4,000 | 274,438 | 10,382 | Dec 08, 2011, 06:25 PM |
Thomas Robert Bain | Director | Dec 01, 2011 | Sale | $68.13 | 2,500 | 170,325 | 8,214 | Dec 05, 2011, 05:59 PM |
Thomas Robert Bain | Director | Nov 17, 2011 | Sale | $62.68 | 2,500 | 156,692 | 24,395 | Nov 17, 2011, 04:54 PM |
Thomas Robert Bain | Director | Nov 16, 2011 | Sale | $63.67 | 2,500 | 159,184 | 26,195 | Nov 17, 2011, 04:54 PM |
Thomas Robert Bain | Director | Nov 15, 2011 | Sale | $63.92 | 2,500 | 159,793 | 28,195 | Nov 17, 2011, 04:54 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Oct 06, 2011 | Sale | $70.09 | 294 | 20,606 | 46,880 | Oct 07, 2011, 05:24 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Oct 05, 2011 | Sale | $70.04 | 6,500 | 455,260 | 47,174 | Oct 07, 2011, 05:24 PM |
Farrell Lauren | VP, Finance | Sep 16, 2011 | Sale | $54.70 | 334 | 18,270 | 1,435 | Sep 20, 2011, 06:15 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 19, 2011 | Sale | $55.02 | 776 | 42,696 | 10,081 | Sep 20, 2011, 06:14 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 16, 2011 | Sale | $55.90 | 4,965 | 277,540 | 15,628 | Sep 20, 2011, 06:14 PM |
Hathaway David R | Chief Medical Officer | Sep 16, 2011 | Sale | $54.71 | 4,384 | 239,827 | 13,331 | Sep 20, 2011, 06:12 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 19, 2011 | Sale | $55.02 | 2,372 | 130,507 | 53,674 | Sep 20, 2011, 06:11 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 16, 2011 | Sale | $55.90 | 15,163 | 847,599 | 70,616 | Sep 20, 2011, 06:11 PM |
McIntyre David | CFO & COO | Sep 19, 2011 | Sale | $54.79 | 16,168 | 885,834 | 15,698 | Sep 20, 2011, 06:08 PM |
McIntyre David | CFO & COO | Sep 16, 2011 | Sale | $55.90 | 7,999 | 447,137 | 24,635 | Sep 20, 2011, 06:08 PM |
Paz Ramon | VP, Quality Assurance | Sep 19, 2011 | Sale | $54.77 | 5,143 | 281,682 | 0 | Sep 20, 2011, 06:07 PM |
Paz Ramon | VP, Quality Assurance | Sep 16, 2011 | Sale | $54.71 | 3,190 | 174,509 | 6,705 | Sep 20, 2011, 06:07 PM |
Schuermann James | VP, Sales & Marketing | Sep 16, 2011 | Sale | $54.71 | 4,384 | 239,827 | 14,328 | Sep 20, 2011, 06:04 PM |
Thomas Robert Bain | Director | Sep 09, 2011 | Sale | $58.65 | 5,000 | 293,250 | 36,370 | Sep 13, 2011, 04:58 PM |
Thomas Robert Bain | Director | Sep 06, 2011 | Sale | $60.35 | 5,000 | 301,750 | 41,370 | Sep 08, 2011, 07:40 PM |
Thomas Robert Bain | Director | Aug 31, 2011 | Sale | $63.27 | 5,000 | 316,350 | 46,370 | Sep 06, 2011, 07:55 PM |
Stockman Robert Bernard | Director | Aug 23, 2011 | Buy | $60.42 | 1,500 | 90,630 | 16,119 | Aug 25, 2011, 05:19 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jun 23, 2011 | Sale | $71.15 | 10,000 | 711,501 | 34,305 | Jun 27, 2011, 05:07 PM |
LaRose Jeffrey | Chief Scientifc Officer | May 25, 2011 | Sale | $70.97 | 1,428 | 101,345 | 822 | May 25, 2011, 06:32 PM |
Thomas Robert Bain | Director | May 19, 2011 | Sale | $76.16 | 5,000 | 380,784 | 53,070 | May 25, 2011, 05:27 PM |
Thomas Robert Bain | Director | May 19, 2011 | Sale | $76.16 | 5,000 | 380,800 | 51,370 | May 23, 2011, 09:38 PM |
Thomas Robert Bain | Director | May 18, 2011 | Sale | $75.47 | 143 | 10,792 | 1,285 | May 19, 2011, 05:50 PM |
BARBERICH TIMOTHY J | Director | May 16, 2011 | Buy | $78.18 | 2,500 | 195,450 | 5,691 | May 17, 2011, 04:37 PM |
Schuermann James | VP, Sales & Marketing | Feb 22, 2011 | Sale | $87.70 | 788 | 69,108 | 6,566 | Feb 24, 2011, 05:54 PM |
Paz Ramon | VP, Quality Assurance | Feb 22, 2011 | Sale | $87.70 | 1,429 | 125,323 | 872 | Feb 24, 2011, 05:53 PM |
McIntyre David | CFO & COO | Feb 22, 2011 | Sale | $87.70 | 2,857 | 250,559 | 2,535 | Feb 24, 2011, 05:43 PM |
LaRose Jeffrey | Chief Scientifc Officer | Feb 22, 2011 | Sale | $87.70 | 893 | 78,316 | 2,250 | Feb 24, 2011, 05:41 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Feb 22, 2011 | Sale | $87.70 | 3,759 | 329,664 | 41,209 | Feb 24, 2011, 05:38 PM |
Farrell Lauren | VP, Finance | Feb 23, 2011 | Sale | $86.64 | 985 | 85,340 | 606 | Feb 24, 2011, 05:34 PM |
Farrell Lauren | VP, Finance | Feb 22, 2011 | Sale | $87.69 | 179 | 15,697 | 1,591 | Feb 24, 2011, 05:34 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jan 25, 2011 | Option Exercise | $38.07 | 10,000 | 380,700 | 46,397 | Jan 26, 2011, 06:34 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Jan 25, 2011 | Sale | $92.51 | 10,000 | 925,100 | 36,397 | Jan 26, 2011, 06:34 PM |
LaRose Jeffrey | Chief Scientifc Officer | Jan 11, 2011 | Option Exercise | $17.38 | 1,400 | 24,332 | 2,222 | Jan 13, 2011, 05:12 PM |
LaRose Jeffrey | Chief Scientifc Officer | Jan 11, 2011 | Sale | $99.00 | 1,400 | 138,600 | 822 | Jan 13, 2011, 05:12 PM |
Paz Ramon | VP, Quality Assurance | Jan 03, 2011 | Option Exercise | $39.37 | 72 | 2,835 | 5,612 | Jan 04, 2011, 05:05 PM |
Paz Ramon | VP, Quality Assurance | Jan 03, 2011 | Sale | $85.90 | 5,612 | 482,071 | 0 | Jan 04, 2011, 05:05 PM |
Farrell Lauren | VP, Finance | Jan 03, 2011 | Option Exercise | $39.37 | 1,072 | 42,205 | 2,307 | Jan 04, 2011, 05:04 PM |
Farrell Lauren | VP, Finance | Jan 03, 2011 | Sale | $86.55 | 1,072 | 92,782 | 1,235 | Jan 04, 2011, 05:04 PM |
Thomas Robert Bain | Director | Dec 17, 2010 | Sale | $86.61 | 10,000 | 866,100 | 56,370 | Dec 21, 2010, 06:01 PM |
APPLE TREE PARTNERS I LP | 10% Owner | Dec 09, 2010 | Sale | $77.86 | 1,000,000 | 77,855,003 | 1,673,962 | Dec 13, 2010, 07:21 PM |
Harrison Seth Loring | Director | Dec 09, 2010 | Sale | $77.86 | 1,000,000 | 77,855,003 | 1,673,962 | Dec 13, 2010, 07:20 PM |
McIntyre David | CFO & COO | Sep 16, 2010 | Sale | $71.41 | 12,565 | 897,318 | 19,798 | Sep 20, 2010, 06:17 PM |
McIntyre David | CFO & COO | Sep 17, 2010 | Sale | $71.36 | 11,602 | 827,919 | 8,194 | Sep 20, 2010, 06:17 PM |
McIntyre David | CFO & COO | Sep 17, 2010 | Sale | $71.36 | 11,602 | 827,919 | 8,194 | Sep 20, 2010, 06:17 PM |
McIntyre David | CFO & COO | Sep 16, 2010 | Sale | $71.41 | 12,565 | 897,318 | 19,798 | Sep 20, 2010, 06:17 PM |
McIntyre David | CFO & COO | Sep 16, 2010 | Sale | $71.41 | 12,565 | 897,318 | 19,798 | Sep 20, 2010, 06:17 PM |
McIntyre David | CFO & COO | Sep 17, 2010 | Sale | $71.36 | 11,602 | 827,919 | 8,194 | Sep 20, 2010, 06:17 PM |
McIntyre David | CFO & COO | Sep 16, 2010 | Sale | $71.41 | 12,565 | 897,318 | 19,798 | Sep 20, 2010, 06:17 PM |
McIntyre David | CFO & COO | Sep 17, 2010 | Sale | $71.36 | 11,602 | 827,919 | 8,194 | Sep 20, 2010, 06:17 PM |
Schuermann James | VP, Sales & Marketing | Sep 16, 2010 | Sale | $71.50 | 2,450 | 175,175 | 7,550 | Sep 20, 2010, 06:12 PM |
Schuermann James | VP, Sales & Marketing | Sep 17, 2010 | Sale | $71.36 | 1,981 | 141,364 | 5,569 | Sep 20, 2010, 06:12 PM |
Schuermann James | VP, Sales & Marketing | Sep 16, 2010 | Sale | $71.50 | 2,450 | 175,175 | 7,550 | Sep 20, 2010, 06:12 PM |
Schuermann James | VP, Sales & Marketing | Sep 17, 2010 | Sale | $71.36 | 1,981 | 141,364 | 5,569 | Sep 20, 2010, 06:12 PM |
Schuermann James | VP, Sales & Marketing | Sep 17, 2010 | Sale | $71.36 | 1,981 | 141,364 | 5,569 | Sep 20, 2010, 06:12 PM |
Schuermann James | VP, Sales & Marketing | Sep 16, 2010 | Sale | $71.50 | 2,450 | 175,175 | 7,550 | Sep 20, 2010, 06:12 PM |
Schuermann James | VP, Sales & Marketing | Sep 16, 2010 | Sale | $71.50 | 2,450 | 175,175 | 7,550 | Sep 20, 2010, 06:12 PM |
Schuermann James | VP, Sales & Marketing | Sep 17, 2010 | Sale | $71.36 | 1,981 | 141,364 | 5,569 | Sep 20, 2010, 06:12 PM |
Paz Ramon | VP, Quality Assurance | Sep 17, 2010 | Sale | $71.42 | 1,422 | 101,559 | 5,540 | Sep 20, 2010, 06:09 PM |
Paz Ramon | VP, Quality Assurance | Sep 16, 2010 | Sale | $71.42 | 1,800 | 128,556 | 6,962 | Sep 20, 2010, 06:09 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 17, 2010 | Sale | $71.36 | 7,200 | 513,792 | 5,424 | Sep 20, 2010, 06:06 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 16, 2010 | Sale | $71.43 | 7,800 | 557,178 | 12,622 | Sep 20, 2010, 06:06 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 17, 2010 | Sale | $71.36 | 7,200 | 513,792 | 5,424 | Sep 20, 2010, 06:06 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 16, 2010 | Sale | $71.43 | 7,800 | 557,178 | 12,622 | Sep 20, 2010, 06:06 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 17, 2010 | Sale | $71.36 | 7,200 | 513,792 | 5,424 | Sep 20, 2010, 06:06 PM |
LaRose Jeffrey | Chief Scientifc Officer | Sep 16, 2010 | Sale | $71.43 | 7,800 | 557,178 | 12,622 | Sep 20, 2010, 06:06 PM |
Hathaway David R | Chief Medical Officer | Sep 17, 2010 | Sale | $71.33 | 4,431 | 316,063 | 5,569 | Sep 20, 2010, 06:02 PM |
Hathaway David R | Chief Medical Officer | Sep 17, 2010 | Sale | $71.33 | 4,431 | 316,063 | 5,569 | Sep 20, 2010, 06:02 PM |
Hathaway David R | Chief Medical Officer | Sep 17, 2010 | Sale | $71.33 | 4,431 | 316,063 | 5,569 | Sep 20, 2010, 06:02 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 16, 2010 | Sale | $71.41 | 9,750 | 696,248 | 44,349 | Sep 20, 2010, 05:49 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 17, 2010 | Sale | $71.35 | 7,952 | 567,375 | 36,397 | Sep 20, 2010, 05:49 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 16, 2010 | Sale | $71.41 | 9,750 | 696,248 | 44,349 | Sep 20, 2010, 05:49 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 17, 2010 | Sale | $71.35 | 7,952 | 567,375 | 36,397 | Sep 20, 2010, 05:49 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 16, 2010 | Sale | $71.41 | 9,750 | 696,248 | 44,349 | Sep 20, 2010, 05:49 PM |
Godshall Douglas Evan | President & Chief Exec Officer | Sep 17, 2010 | Sale | $71.35 | 7,952 | 567,375 | 36,397 | Sep 20, 2010, 05:49 PM |
Farrell Lauren | VP, Finance | Sep 16, 2010 | Option Exercise | $24.12 | 1,285 | 30,999 | 2,520 | Sep 17, 2010, 07:06 PM |
Farrell Lauren | VP, Finance | Sep 17, 2010 | Sale | $71.39 | 1,285 | 91,736 | 1,235 | Sep 17, 2010, 07:06 PM |
Farrell Lauren | VP, Finance | Sep 16, 2010 | Sale | $73.65 | 750 | 55,241 | 1,540 | Sep 17, 2010, 07:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Wade Denis Newell | Director | 08/23/2016 | 288,028 |
Wade Denis Newell | Director | 08/23/2016 | 333,500 |
Thomas Robert Bain | Director | 08/23/2016 | 261,580 |
Thomas Robert Bain | Director | 08/23/2016 | 58,000 |
Strong Mark | Senior VP, R&D and Quality | 08/23/2016 | 203,754 |
Stockman Robert Bernard | Director | 08/23/2016 | 1,033,212 |
Schuermann James | SVP, Sales & Marketing | 08/23/2016 | 698,494 |
OESTERLE STEPHEN N | Director | 08/23/2016 | 58,000 |
MCAREE PETER F | SVP, CFO and Treasurer | 08/23/2016 | 1,102,290 |
LaRose Jeffrey | Chief Scientific Officer | 08/23/2016 | 723,956 |
LARKIN C RAYMOND JR | Director | 08/23/2016 | 464,000 |
Knopf Lawrence J | General Counsel | 08/23/2016 | 1,021,264 |
Harrison Seth Loring | Director | 08/23/2016 | 203,000 |
Harrison Seth Loring | Director | 08/23/2016 | 866,288 |
Harrison Seth Loring | Director | 08/23/2016 | 7,736,794 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/23/2016 | 4,892,010 |
FELDMANN CYNTHIA L | Director | 08/23/2016 | 275,500 |
BARBERICH TIMOTHY J | Director | 08/23/2016 | 644,206 |
Strong Mark | Senior VP, R&D and Quality | 07/22/2016 | 108,206 |
MCAREE PETER F | SVP, CFO and Treasurer | 07/11/2016 | 180,250 |
Schuermann James | SVP, Sales & Marketing | 07/01/2016 | 57,770 |
Schuermann James | SVP, Sales & Marketing | 04/01/2016 | 31,360 |
OESTERLE STEPHEN N | Director | 02/29/2016 | 32,170 |
Strong Mark | Senior VP, R&D and Quality | 02/25/2016 | 11,724 |
Schuermann James | SVP, Sales & Marketing | 02/25/2016 | 17,573 |
MCAREE PETER F | SVP, CFO and Treasurer | 02/25/2016 | 20,220 |
LaRose Jeffrey | Chief Scientific Officer | 02/25/2016 | 10,330 |
Knopf Lawrence J | General Counsel | 02/25/2016 | 12,335 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/25/2016 | 58,101 |
Strong Mark | Senior VP, R&D and Quality | 02/24/2016 | 24,255 |
Schuermann James | SVP, Sales & Marketing | 02/24/2016 | 9,250 |
MCAREE PETER F | SVP, CFO and Treasurer | 02/24/2016 | 14,182 |
Leadley Katrin | Chief Medical Officer | 02/24/2016 | 28,333 |
LaRose Jeffrey | Chief Scientific Officer | 02/24/2016 | 6,644 |
Knopf Lawrence J | General Counsel | 02/24/2016 | 9,261 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/24/2016 | 37,300 |
Schuermann James | SVP, Sales & Marketing | 02/08/2016 | 23,789 |
MCAREE PETER F | SVP, CFO and Treasurer | 02/08/2016 | 25,792 |
LaRose Jeffrey | Chief Scientific Officer | 02/08/2016 | 20,456 |
Knopf Lawrence J | General Counsel | 02/08/2016 | 20,729 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/08/2016 | 65,700 |
Schuermann James | SVP, Sales & Marketing | 01/04/2016 | 48,510 |
Yocher Robert E | SVP Regulatory Affairs | 12/22/2015 | 15,520 |
Schuermann James | SVP, Sales & Marketing | 12/22/2015 | 55,767 |
LaRose Jeffrey | Chief Scientific Officer | 12/22/2015 | 56,646 |
Knopf Lawrence J | General Counsel | 12/22/2015 | 33,482 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/22/2015 | 200,205 |
Schuermann James | SVP, Sales & Marketing | 12/21/2015 | 25,737 |
Schuermann James | SVP, Sales & Marketing | 10/01/2015 | 53,012 |
Strong Mark | Senior VP, R&D and Quality | 10/01/2015 | 137,955 |
Leadley Katrin | Chief Medical Officer | 08/26/2015 | 300,092 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 08/03/2015 | 3,165,072 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 07/31/2015 | 6,900,000 |
Strong Mark | Senior VP, R&D and Quality | 07/22/2015 | 165,112 |
MCAREE PETER F | SVP, CFO and Treasurer | 07/10/2015 | 229,259 |
Schuermann James | SVP, Sales & Marketing | 07/01/2015 | 72,780 |
Yocher Robert E | SVP Regulatory Affairs | 06/24/2015 | 64,173 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 04/21/2015 | 1,619,132 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 04/21/2015 | 145,098 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 04/20/2015 | 7,096,523 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 04/17/2015 | 5,121,570 |
Schuermann James | SVP, Sales & Marketing | 04/01/2015 | 86,339 |
Knopf Lawrence J | General Counsel | 03/30/2015 | 154,619 |
Yocher Robert E | SVP Regulatory Affairs | 02/25/2015 | 18,801 |
Strong Mark | Senior VP, R&D and Quality | 02/25/2015 | 35,376 |
Schuermann James | SVP, Sales & Marketing | 02/25/2015 | 51,407 |
MCAREE PETER F | SVP, CFO and Treasurer | 02/25/2015 | 41,542 |
LaRose Jeffrey | Chief Scientific Officer | 02/25/2015 | 30,303 |
Knopf Lawrence J | General Counsel | 02/25/2015 | 35,718 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/25/2015 | 165,006 |
Yocher Robert E | SVP Regulatory Affairs | 02/09/2015 | 26,783 |
Schuermann James | SVP, Sales & Marketing | 02/09/2015 | 45,213 |
MCAREE PETER F | SVP, CFO and Treasurer | 02/09/2015 | 44,205 |
LaRose Jeffrey | Chief Scientific Officer | 02/09/2015 | 42,452 |
Knopf Lawrence J | General Counsel | 02/09/2015 | 44,100 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/09/2015 | 147,014 |
Schuermann James | SVP, Sales & Marketing | 01/02/2015 | 30,609 |
Schuermann James | SVP, Sales & Marketing | 01/02/2015 | 103,869 |
Yocher Robert E | SVP Regulatory Affairs | 12/22/2014 | 24,336 |
Schuermann James | SVP, Sales & Marketing | 12/22/2014 | 176,724 |
LaRose Jeffrey | Chief Scientific Officer | 12/22/2014 | 224,205 |
Knopf Lawrence J | General Counsel | 12/22/2014 | 52,648 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/22/2014 | 513,110 |
Schuermann James | SVP, Sales & Marketing | 12/01/2014 | 33,465 |
Schuermann James | SVP, Sales & Marketing | 12/01/2014 | 109,590 |
Thomas Robert Bain | Director | 11/14/2014 | 40,015 |
Thomas Robert Bain | Director | 11/04/2014 | 76,990 |
Schuermann James | SVP, Sales & Marketing | 11/03/2014 | 34,620 |
Schuermann James | SVP, Sales & Marketing | 11/03/2014 | 114,540 |
Strong Mark | Senior VP, R&D and Quality | 10/01/2014 | 202,020 |
LaRose Jeffrey | Chief Scientific Officer | 09/15/2014 | 11,567 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 09/15/2014 | 5,008,089 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 09/12/2014 | 2,685,904 |
Knopf Lawrence J | General Counsel | 09/10/2014 | 36,442 |
LaRose Jeffrey | Chief Scientific Officer | 08/19/2014 | 78,183 |
LaRose Jeffrey | Chief Scientific Officer | 08/19/2014 | 177,610 |
Thomas Robert Bain | Director | 08/18/2014 | 81,970 |
MCAREE PETER F | SVP, CFO and Treasurer | 07/10/2014 | 175,453 |
Yocher Robert E | SVP, Regulatory & Quality | 06/24/2014 | 73,372 |
Thomas Robert Bain | Director | 05/19/2014 | 93,390 |
Thomas Robert Bain | Director | 05/14/2014 | 93,160 |
Thomas Robert Bain | Director | 05/07/2014 | 187,393 |
LaRose Jeffrey | Chief Scientific Officer | 05/01/2014 | 77,834 |
LaRose Jeffrey | Chief Scientific Officer | 05/01/2014 | 196,024 |
LaRose Jeffrey | Chief Scientific Officer | 04/01/2014 | 61,590 |
LaRose Jeffrey | Chief Scientific Officer | 04/01/2014 | 205,387 |
Knopf Lawrence J | General Counsel | 03/31/2014 | 158,970 |
MCAREE PETER F | SVP, CFO and Treasurer | 03/11/2014 | 43,575 |
Schuermann James | SVP, Sales & Marketing | 03/10/2014 | 47,580 |
Schuermann James | SVP, Sales & Marketing | 03/10/2014 | 188,440 |
LaRose Jeffrey | Chief Scientific Officer | 03/10/2014 | 469,484 |
Hathaway David R | Chief Medical Officer | 03/11/2014 | 50,672 |
Hathaway David R | Chief Medical Officer | 03/10/2014 | 5,406 |
Hathaway David R | Chief Medical Officer | 03/11/2014 | 267,140 |
Hathaway David R | Chief Medical Officer | 03/10/2014 | 152,095 |
LaRose Jeffrey | Chief Scientific Officer | 03/03/2014 | 34,014 |
LaRose Jeffrey | Chief Scientific Officer | 03/03/2014 | 202,975 |
Thomas Robert Bain | Director | 12/18/2013 | 640,538 |
Thomas Robert Bain | Director | 05/23/2013 | 211,370 |
Thomas Robert Bain | Director | 05/25/2012 | 396,450 |
Thomas Robert Bain | Director | 09/06/2011 | 301,750 |
Yocher Robert E | SVP, Regulatory & Quality | 02/10/2014 | 40,476 |
LaRose Jeffrey | Chief Scientific Officer | 02/10/2014 | 64,787 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/10/2014 | 229,616 |
Schuermann James | SVP, Sales & Marketing | 02/10/2014 | 76,723 |
Knopf Lawrence J | General Counsel | 02/10/2014 | 67,552 |
MCAREE PETER F | SVP, CFO and Treasurer | 02/10/2014 | 67,559 |
LaRose Jeffrey | Chief Scientific Officer | 02/03/2014 | 33,360 |
LaRose Jeffrey | Chief Scientific Officer | 02/03/2014 | 214,578 |
LaRose Jeffrey | Chief Scientific Officer | 01/07/2014 | 1,534,200 |
Knopf Lawrence J | General Counsel | 01/06/2014 | 83,948 |
Harrison Seth Loring | Director | 01/06/2014 | 785,285 |
Yocher Robert E | SVP, Regulatory & Quality | 12/23/2013 | 43,843 |
Schuermann James | SVP, Sales & Marketing | 12/23/2013 | 109,637 |
Schuermann James | SVP, Sales & Marketing | 12/20/2013 | 128,848 |
LaRose Jeffrey | Chief Scientific Officer | 12/20/2013 | 110,002 |
LaRose Jeffrey | Chief Scientific Officer | 12/23/2013 | 170,762 |
Knopf Lawrence J | General Counsel | 12/23/2013 | 65,786 |
Hathaway David R | Chief Medical Officer | 12/23/2013 | 54,800 |
Hathaway David R | Chief Medical Officer | 12/20/2013 | 55,851 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/23/2013 | 394,883 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/20/2013 | 248,013 |
Thomas Robert Bain | Director | 12/06/2013 | 285,870 |
Thomas Robert Bain | Director | 12/04/2013 | 238,850 |
LaRose Jeffrey | Chief Scientific Officer | 12/02/2013 | 34,733 |
LaRose Jeffrey | Chief Scientific Officer | 12/02/2013 | 210,034 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/02/2013 | 455,780 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/02/2013 | 1,241,614 |
Godshall Douglas Evan | President & Chief Exec Officer | 11/15/2013 | 359,200 |
Godshall Douglas Evan | President & Chief Exec Officer | 11/15/2013 | 900,000 |
Godshall Douglas Evan | President & Chief Exec Officer | 11/07/2013 | 109,920 |
Godshall Douglas Evan | President & Chief Exec Officer | 11/07/2013 | 664,503 |
LaRose Jeffrey | Chief Scientific Officer | 11/07/2013 | 36,280 |
LaRose Jeffrey | Chief Scientific Officer | 11/07/2013 | 186,174 |
LaRose Jeffrey | Chief Scientific Officer | 09/03/2013 | 34,210 |
LaRose Jeffrey | Chief Scientific Officer | 09/03/2013 | 171,249 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/03/2013 | 103,620 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/03/2013 | 624,651 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/01/2013 | 451,100 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/01/2013 | 1,705,320 |
LaRose Jeffrey | Chief Scientific Officer | 08/01/2013 | 34,363 |
LaRose Jeffrey | Chief Scientific Officer | 08/01/2013 | 202,888 |
Schuermann James | SVP, Sales & Marketing | 08/01/2013 | 93,070 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/25/2013 | 448,957 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/29/2013 | 90,144 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/26/2013 | 453,297 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/25/2013 | 1,182,293 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/29/2013 | 693,846 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/26/2013 | 1,191,323 |
MCAREE PETER F | SVP, CFO and Treasurer | 07/10/2013 | 276,061 |
LaRose Jeffrey | Chief Scientific Officer | 07/01/2013 | 34,820 |
LaRose Jeffrey | Chief Scientific Officer | 07/01/2013 | 208,866 |
Harrison Seth Loring | Director | 07/01/2013 | 1,253,734 |
Knopf Lawrence J | General Counsel | 06/26/2013 | 94,240 |
Yocher Robert E | SVP, Regulatory & Quality | 06/25/2013 | 109,519 |
LaRose Jeffrey | Chief Scientific Officer | 06/17/2013 | 36,476 |
LaRose Jeffrey | Chief Scientific Officer | 06/17/2013 | 198,594 |
Thomas Robert Bain | Director | 06/06/2013 | 240,200 |
Thomas Robert Bain | Director | 05/30/2013 | 5,361 |
Thomas Robert Bain | Director | 05/29/2013 | 66,300 |
Thomas Robert Bain | Director | 05/28/2013 | 26,046 |
Thomas Robert Bain | Director | 05/28/2013 | 236,781 |
Hathaway David R | Chief Medical Officer | 05/28/2013 | 86,317 |
Hathaway David R | Chief Medical Officer | 05/28/2013 | 564,027 |
Hathaway David R | Chief Medical Officer | 05/22/2013 | 46,920 |
Hathaway David R | Chief Medical Officer | 05/21/2013 | 334,401 |
Hathaway David R | Chief Medical Officer | 05/20/2013 | 194,000 |
Hathaway David R | Chief Medical Officer | 05/22/2013 | 228,360 |
Hathaway David R | Chief Medical Officer | 05/21/2013 | 1,641,378 |
Hathaway David R | Chief Medical Officer | 05/20/2013 | 977,236 |
Thomas Robert Bain | Director | 05/21/2013 | 19,538 |
Thomas Robert Bain | Director | 05/20/2013 | 386,645 |
Thomas Robert Bain | Director | 05/20/2013 | 244,539 |
Wade Denis Newell | Director | 05/20/2013 | 396,000 |
Knopf Lawrence J | General Counsel | 05/20/2013 | 195,440 |
LaRose Jeffrey | Chief Scientific Officer | 05/20/2013 | 936,261 |
Schuermann James | SVP, Sales & Marketing | 05/01/2013 | 97,200 |
Knopf Lawrence J | General Counsel | 03/28/2013 | 221,358 |
Schuermann James | SVP, Sales & Marketing | 02/01/2013 | 90,590 |
Yocher Robert E | SVP, Regulatory & Quality | 12/21/2012 | 34,950 |
Schuermann James | SVP, Sales & Marketing | 12/21/2012 | 87,300 |
Schuermann James | SVP, Sales & Marketing | 12/20/2012 | 43,672 |
LaRose Jeffrey | Chief Scientific Officer | 12/20/2012 | 85,538 |
LaRose Jeffrey | Chief Scientific Officer | 12/21/2012 | 133,493 |
Knopf Lawrence J | General Counsel | 12/21/2012 | 52,425 |
Hathaway David R | Chief Medical Officer | 12/21/2012 | 43,647 |
Hathaway David R | Chief Medical Officer | 12/20/2012 | 44,082 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/21/2012 | 314,140 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/20/2012 | 196,031 |
Farrell Lauren | VP, Finance | 12/21/2012 | 33,225 |
Farrell Lauren | VP, Finance | 12/20/2012 | 19,945 |
Harrison Seth Loring | Director | 12/14/2012 | 6,150,531 |
Wade Denis Newell | Director | 12/13/2012 | 175,203 |
Wade Denis Newell | Director | 12/12/2012 | 27,803 |
Harrison Seth Loring | Director | 12/13/2012 | 8,825,061 |
Harrison Seth Loring | Director | 12/12/2012 | 939,294 |
Harrison Seth Loring | Director | 12/11/2012 | 4,549,320 |
Hathaway David R | Chief Medical Officer | 12/13/2012 | 457,404 |
Hathaway David R | Chief Medical Officer | 12/12/2012 | 490,860 |
Hathaway David R | Chief Medical Officer | 12/11/2012 | 493,020 |
Harrison Seth Loring | Director | 12/10/2012 | 2,117,265 |
Harrison Seth Loring | Director | 12/07/2012 | 3,862,886 |
Thomas Robert Bain | Director | 12/03/2012 | 112,840 |
Thomas Robert Bain | Director | 12/04/2012 | 289,296 |
Schuermann James | SVP, Sales & Marketing | 12/03/2012 | 204,315 |
LaRose Jeffrey | Chief Scientific Officer | 12/03/2012 | 113,407 |
Schuermann James | SVP, Sales & Marketing | 11/21/2012 | 67,175 |
LaRose Jeffrey | Chief Scientific Officer | 11/21/2012 | 76,327 |
Godshall Douglas Evan | President & Chief Exec Officer | 11/21/2012 | 320,512 |
Farrell Lauren | VP, Finance | 11/21/2012 | 46,087 |
Schuermann James | SVP, Sales & Marketing | 11/01/2012 | 84,010 |
Farrell Lauren | VP, Finance | 09/18/2012 | 6,378 |
Farrell Lauren | VP, Finance | 09/17/2012 | 23,557 |
Schuermann James | SVP, Sales & Marketing | 09/18/2012 | 84,584 |
Schuermann James | SVP, Sales & Marketing | 09/17/2012 | 308,461 |
LaRose Jeffrey | Chief Scientific Officer | 09/17/2012 | 404,347 |
LaRose Jeffrey | Chief Scientific Officer | 09/18/2012 | 110,930 |
Hathaway David R | Chief Medical Officer | 09/18/2012 | 84,676 |
Hathaway David R | Chief Medical Officer | 09/17/2012 | 308,364 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/18/2012 | 303,600 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/18/2012 | 1,034,785 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/17/2012 | 1,233,476 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/28/2012 | 125,871 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/24/2012 | 74,865 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/28/2012 | 283,895 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/24/2012 | 167,027 |
Thomas Robert Bain | Director | 08/23/2012 | 444,000 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/17/2012 | 101,025 |
Godshall Douglas Evan | President & Chief Exec Officer | 08/17/2012 | 222,450 |
Schuermann James | SVP, Sales & Marketing | 08/01/2012 | 89,040 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/17/2012 | 295,350 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/17/2012 | 677,405 |
Harrison Seth Loring | Director | 07/16/2012 | 1,575,067 |
Harrison Seth Loring | Director | 07/13/2012 | 745,110 |
Harrison Seth Loring | Director | 07/12/2012 | 15,750 |
Harrison Seth Loring | Director | 07/16/2012 | 175,098 |
Harrison Seth Loring | Director | 07/13/2012 | 82,800 |
Harrison Seth Loring | Director | 07/12/2012 | 1,710 |
Harrison Seth Loring | Director | 07/02/2012 | 56,700 |
Harrison Seth Loring | Director | 07/03/2012 | 4,680 |
Harrison Seth Loring | Director | 07/02/2012 | 6,300 |
Harrison Seth Loring | Director | 07/03/2012 | 42,570 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/02/2012 | 197,050 |
Godshall Douglas Evan | President & Chief Exec Officer | 07/02/2012 | 450,000 |
Schuermann James | VP, Sales & Marketing | 07/02/2012 | 90,000 |
Yocher Robert E | SVP, Regulatory & Quality | 06/25/2012 | 91,595 |
Godshall Douglas Evan | President & Chief Exec Officer | 06/18/2012 | 97,025 |
Godshall Douglas Evan | President & Chief Exec Officer | 06/18/2012 | 214,525 |
Thomas Robert Bain | Director | 06/13/2012 | 60,861 |
Thomas Robert Bain | Director | 06/12/2012 | 428,050 |
Schuermann James | VP, Sales & Marketing | 06/08/2012 | 85,000 |
Stockman Robert Bernard | Director | 06/07/2012 | 249,895 |
Thomas Robert Bain | Director | 05/25/2012 | 33,615 |
Thomas Robert Bain | Director | 05/23/2012 | 74,971 |
LaRose Jeffrey | Chief Scientifc Officer | 05/21/2012 | 105,535 |
Thomas Robert Bain | Director | 05/18/2012 | 507,112 |
Godshall Douglas Evan | President & Chief Exec Officer | 05/17/2012 | 95,500 |
Godshall Douglas Evan | President & Chief Exec Officer | 05/17/2012 | 200,575 |
Thomas Robert Bain | Director | 05/15/2012 | 403,650 |
Thomas Robert Bain | Director | 05/16/2012 | 400,000 |
Farrell Lauren | VP, Finance | 05/11/2012 | 38,822 |
Schuermann James | VP, Sales & Marketing | 05/09/2012 | 24,137 |
LaRose Jeffrey | Chief Scientifc Officer | 05/09/2012 | 63,236 |
Godshall Douglas Evan | President & Chief Exec Officer | 05/09/2012 | 265,668 |
Farrell Lauren | VP, Finance | 05/09/2012 | 18,431 |
Schuermann James | VP, Sales & Marketing | 05/01/2012 | 197,772 |
Farrell Lauren | VP, Finance | 04/26/2012 | 32,096 |
Farrell Lauren | VP, Finance | 04/26/2012 | 100,308 |
Godshall Douglas Evan | President & Chief Exec Officer | 04/26/2012 | 99,850 |
Godshall Douglas Evan | President & Chief Exec Officer | 04/26/2012 | 193,975 |
Harrison Seth Loring | Director | 04/26/2012 | 231,951 |
Harrison Seth Loring | Director | 04/26/2012 | 2,087,486 |
Knopf Lawrence J | General Counsel | 03/28/2012 | 152,438 |
Thomas Robert Bain | Director | 03/06/2012 | 421,909 |
Wade Denis Newell | Director | 02/28/2012 | 447,000 |
Wade Denis Newell | Director | 02/27/2012 | 885,000 |
Wade Denis Newell | Director | 02/24/2012 | 441,000 |
Wade Denis Newell | Director | 02/22/2012 | 444,000 |
Thomas Robert Bain | Director | 02/27/2012 | 9,052 |
Wade Denis Newell | Director | 02/28/2012 | 447,000 |
Thomas Robert Bain | Director | 02/27/2012 | 34,359 |
Thomas Robert Bain | Director | 02/24/2012 | 101,824 |
Thomas Robert Bain | Director | 02/23/2012 | 74,000 |
Wade Denis Newell | Director | 02/24/2012 | 441,000 |
Wade Denis Newell | Director | 02/27/2012 | 885,000 |
Thomas Robert Bain | Director | 02/21/2012 | 42,022 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/17/2012 | 66,728 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/16/2012 | 103,225 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/17/2012 | 293,610 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/16/2012 | 187,500 |
Farrell Lauren | VP, Finance | 02/16/2012 | 45,000 |
Schuermann James | VP, Sales & Marketing | 02/01/2012 | 69,130 |
Godshall Douglas Evan | President & Chief Exec Officer | 01/31/2012 | 350,350 |
Godshall Douglas Evan | President & Chief Exec Officer | 01/06/2012 | 271,449 |
Godshall Douglas Evan | President & Chief Exec Officer | 01/05/2012 | 80,592 |
Farrell Lauren | VP, Finance | 01/06/2012 | 35,928 |
Schuermann James | VP, Sales & Marketing | 01/05/2012 | 56,560 |
Schuermann James | VP, Sales & Marketing | 01/03/2012 | 13,440 |
Farrell Lauren | VP, Finance | 01/03/2012 | 47,040 |
Schuermann James | VP, Sales & Marketing | 12/20/2011 | 37,404 |
LaRose Jeffrey | Chief Scientifc Officer | 12/20/2011 | 73,177 |
Hathaway David R | Chief Medical Officer | 12/20/2011 | 37,817 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/20/2011 | 167,994 |
Farrell Lauren | VP, Finance | 12/20/2011 | 17,132 |
McIntyre David | CFO & COO | 12/19/2011 | 219,475 |
McIntyre David | CFO & COO | 12/20/2011 | 213,082 |
McIntyre David | CFO & COO | 12/19/2011 | 502,551 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/13/2011 | 56,000 |
Godshall Douglas Evan | President & Chief Exec Officer | 12/09/2011 | 455,935 |
Schuermann James | VP, Sales & Marketing | 12/07/2011 | 274,438 |
Thomas Robert Bain | Director | 12/01/2011 | 170,325 |
Thomas Robert Bain | Director | 11/17/2011 | 156,692 |
Thomas Robert Bain | Director | 11/16/2011 | 159,184 |
Thomas Robert Bain | Director | 11/15/2011 | 159,793 |
Godshall Douglas Evan | President & Chief Exec Officer | 10/06/2011 | 20,606 |
Godshall Douglas Evan | President & Chief Exec Officer | 10/05/2011 | 455,260 |
Farrell Lauren | VP, Finance | 09/16/2011 | 18,270 |
LaRose Jeffrey | Chief Scientifc Officer | 09/19/2011 | 42,696 |
LaRose Jeffrey | Chief Scientifc Officer | 09/16/2011 | 277,540 |
Hathaway David R | Chief Medical Officer | 09/16/2011 | 239,827 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/19/2011 | 130,507 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/16/2011 | 847,599 |
McIntyre David | CFO & COO | 09/19/2011 | 885,834 |
McIntyre David | CFO & COO | 09/16/2011 | 447,137 |
Paz Ramon | VP, Quality Assurance | 09/19/2011 | 281,682 |
Paz Ramon | VP, Quality Assurance | 09/16/2011 | 174,509 |
Schuermann James | VP, Sales & Marketing | 09/16/2011 | 239,827 |
Thomas Robert Bain | Director | 09/09/2011 | 293,250 |
Thomas Robert Bain | Director | 09/06/2011 | 301,750 |
Thomas Robert Bain | Director | 08/31/2011 | 316,350 |
Stockman Robert Bernard | Director | 08/23/2011 | 90,630 |
Godshall Douglas Evan | President & Chief Exec Officer | 06/23/2011 | 711,501 |
LaRose Jeffrey | Chief Scientifc Officer | 05/25/2011 | 101,345 |
Thomas Robert Bain | Director | 05/19/2011 | 380,784 |
Thomas Robert Bain | Director | 05/19/2011 | 380,800 |
Thomas Robert Bain | Director | 05/18/2011 | 10,792 |
BARBERICH TIMOTHY J | Director | 05/16/2011 | 195,450 |
Schuermann James | VP, Sales & Marketing | 02/22/2011 | 69,108 |
Paz Ramon | VP, Quality Assurance | 02/22/2011 | 125,323 |
McIntyre David | CFO & COO | 02/22/2011 | 250,559 |
LaRose Jeffrey | Chief Scientifc Officer | 02/22/2011 | 78,316 |
Godshall Douglas Evan | President & Chief Exec Officer | 02/22/2011 | 329,664 |
Farrell Lauren | VP, Finance | 02/23/2011 | 85,340 |
Farrell Lauren | VP, Finance | 02/22/2011 | 15,697 |
Godshall Douglas Evan | President & Chief Exec Officer | 01/25/2011 | 380,700 |
Godshall Douglas Evan | President & Chief Exec Officer | 01/25/2011 | 925,100 |
LaRose Jeffrey | Chief Scientifc Officer | 01/11/2011 | 24,332 |
LaRose Jeffrey | Chief Scientifc Officer | 01/11/2011 | 138,600 |
Paz Ramon | VP, Quality Assurance | 01/03/2011 | 2,835 |
Paz Ramon | VP, Quality Assurance | 01/03/2011 | 482,071 |
Farrell Lauren | VP, Finance | 01/03/2011 | 42,205 |
Farrell Lauren | VP, Finance | 01/03/2011 | 92,782 |
Thomas Robert Bain | Director | 12/17/2010 | 866,100 |
APPLE TREE PARTNERS I LP | 10% Owner | 12/09/2010 | 77,855,003 |
Harrison Seth Loring | Director | 12/09/2010 | 77,855,003 |
McIntyre David | CFO & COO | 09/16/2010 | 897,318 |
McIntyre David | CFO & COO | 09/17/2010 | 827,919 |
McIntyre David | CFO & COO | 09/17/2010 | 827,919 |
McIntyre David | CFO & COO | 09/16/2010 | 897,318 |
McIntyre David | CFO & COO | 09/16/2010 | 897,318 |
McIntyre David | CFO & COO | 09/17/2010 | 827,919 |
McIntyre David | CFO & COO | 09/16/2010 | 897,318 |
McIntyre David | CFO & COO | 09/17/2010 | 827,919 |
Schuermann James | VP, Sales & Marketing | 09/16/2010 | 175,175 |
Schuermann James | VP, Sales & Marketing | 09/17/2010 | 141,364 |
Schuermann James | VP, Sales & Marketing | 09/16/2010 | 175,175 |
Schuermann James | VP, Sales & Marketing | 09/17/2010 | 141,364 |
Schuermann James | VP, Sales & Marketing | 09/17/2010 | 141,364 |
Schuermann James | VP, Sales & Marketing | 09/16/2010 | 175,175 |
Schuermann James | VP, Sales & Marketing | 09/16/2010 | 175,175 |
Schuermann James | VP, Sales & Marketing | 09/17/2010 | 141,364 |
Paz Ramon | VP, Quality Assurance | 09/17/2010 | 101,559 |
Paz Ramon | VP, Quality Assurance | 09/16/2010 | 128,556 |
LaRose Jeffrey | Chief Scientifc Officer | 09/17/2010 | 513,792 |
LaRose Jeffrey | Chief Scientifc Officer | 09/16/2010 | 557,178 |
LaRose Jeffrey | Chief Scientifc Officer | 09/17/2010 | 513,792 |
LaRose Jeffrey | Chief Scientifc Officer | 09/16/2010 | 557,178 |
LaRose Jeffrey | Chief Scientifc Officer | 09/17/2010 | 513,792 |
LaRose Jeffrey | Chief Scientifc Officer | 09/16/2010 | 557,178 |
Hathaway David R | Chief Medical Officer | 09/17/2010 | 316,063 |
Hathaway David R | Chief Medical Officer | 09/17/2010 | 316,063 |
Hathaway David R | Chief Medical Officer | 09/17/2010 | 316,063 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/16/2010 | 696,248 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/17/2010 | 567,375 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/16/2010 | 696,248 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/17/2010 | 567,375 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/16/2010 | 696,248 |
Godshall Douglas Evan | President & Chief Exec Officer | 09/17/2010 | 567,375 |
Farrell Lauren | VP, Finance | 09/16/2010 | 30,999 |
Farrell Lauren | VP, Finance | 09/17/2010 | 91,736 |
Farrell Lauren | VP, Finance | 09/16/2010 | 55,241 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...